Shanghai Bio-heart (2185) Announces UK MHRA Registration of Iberis® RDN System

Bulletin Express

10/31

Shanghai Bio-heart Biological Technology Co., Ltd. (2185) announced that a subsidiary of the company, Shanghai AngioCare Medical Technology Co., Ltd., in collaboration with Biosensors International Group, Ltd., has successfully registered the Iberis® Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System (Iberis® RDN system) with the Medicines & Healthcare products Regulatory Agency (MHRA) in the United Kingdom.

According to the announcement, Iberis® RDN system is approved for both transradial and transfemoral approaches, and it previously received CE marking in Europe in 2016. The registration is part of a broader strategic partnership between AngioCare and Biosensors that encompasses commercialization in multiple regions, including the European Union, the Asia–Pacific region, and Latin America.

The company notes that there is no guarantee Iberis® RDN system will be successfully developed and marketed, and shareholders and potential investors are advised to exercise due care when dealing in its shares.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1137849417"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1137849417\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1137849417?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-31 00:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137849417","market":"hk","top_or_hot":-1,"title":"Shanghai Bio-heart (2185) Announces UK MHRA Registration of Iberis® RDN System","media":"Bulletin Express","content":"<p>Shanghai Bio-heart Biological Technology Co., Ltd. (2185) announced that a subsidiary of the company, Shanghai AngioCare Medical Technology Co., Ltd., in collaboration with Biosensors International Group, Ltd., has successfully registered the Iberis® Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System (Iberis® RDN system) with the Medicines & Healthcare products Regulatory Agency (MHRA) in the United Kingdom.</p>\n<p>According to the announcement, Iberis® RDN system is approved for both transradial and transfemoral approaches, and it previously received CE marking in Europe in 2016. The registration is part of a broader strategic partnership between AngioCare and Biosensors that encompasses commercialization in multiple regions, including the European Union, the Asia–Pacific region, and Latin America.</p>\n<p>The company notes that there is no guarantee Iberis® RDN system will be successfully developed and marketed, and shareholders and potential investors are advised to exercise due care when dealing in its shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Bio-heart (2185) Announces UK MHRA Registration of Iberis® RDN System</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Bio-heart (2185) Announces UK MHRA Registration of Iberis® RDN System\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2025-10-31 00:57</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shanghai Bio-heart Biological Technology Co., Ltd. (2185) announced that a subsidiary of the company, Shanghai AngioCare Medical Technology Co., Ltd., in collaboration with Biosensors International Group, Ltd., has successfully registered the Iberis® Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System (Iberis® RDN system) with the Medicines & Healthcare products Regulatory Agency (MHRA) in the United Kingdom.</p>\n<p>According to the announcement, Iberis® RDN system is approved for both transradial and transfemoral approaches, and it previously received CE marking in Europe in 2016. The registration is part of a broader strategic partnership between AngioCare and Biosensors that encompasses commercialization in multiple regions, including the European Union, the Asia–Pacific region, and Latin America.</p>\n<p>The company notes that there is no guarantee Iberis® RDN system will be successfully developed and marketed, and shareholders and potential investors are advised to exercise due care when dealing in its shares.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02185","symbol_name":"百心安-B","start_time":0,"source_url":"","article_id":"1137849417","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137849417","pubTimestamp":1761843458,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Bio-heart Biological Technology Co., Ltd. (2185) announced that a subsidiary of the company, Shanghai AngioCare Medical Technology Co., Ltd., in collaboration with Biosensors International...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02185":"百心安-B"},"translate_title":"上海生物心脏(2185)宣布Iberis获得英国MHRA注册®RDN系统","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02185":1},"content_text":"Shanghai Bio-heart Biological Technology Co., Ltd. (2185) announced that a subsidiary of the company, Shanghai AngioCare Medical Technology Co., Ltd., in collaboration with Biosensors International Group, Ltd., has successfully registered the Iberis® Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System (Iberis® RDN system) with the Medicines & Healthcare products Regulatory Agency (MHRA) in the United Kingdom.\nAccording to the announcement, Iberis® RDN system is approved for both transradial and transfemoral approaches, and it previously received CE marking in Europe in 2016. The registration is part of a broader strategic partnership between AngioCare and Biosensors that encompasses commercialization in multiple regions, including the European Union, the Asia–Pacific region, and Latin America.\nThe company notes that there is no guarantee Iberis® RDN system will be successfully developed and marketed, and shareholders and potential investors are advised to exercise due care when dealing in its shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}